Health
Pfizer, BioNTech Seek US Emergency OK for COVID-19 Vaccine in Adolescents – Voice of America
Pfizer and its German partner BioNTech asked U.S. regulators Friday to allow the emergency use of their vaccine in adolescents ages 12 to 15. The vaccine is currently…
Pfizer and its German partner BioNTech asked U.S. regulators Friday to allow the emergency use of their vaccine in adolescents ages 12 to 15.
The vaccine is currently authorized for emergency use in the United States for people age 16 and older. The companies said Friday that they requested an expansion of the authorization from the U.S. Food and Drug Administration (FDA) to include the younger age group.
In March, the drugmakers said the vaccine was found to be safe and effective and had produced…
-
General16 hours agoChina and Philippines trade blame over latest South China Sea clash
-
General17 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
General17 hours agoWhy the nation needs the Nationals to ditch Net Zero
-
General16 hours agoOf saints and sinners | The Spectator Australia